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**RESPONSE**

Dear colleagues,

We agree with your analysis and believe that a higher circulation of the criteria of eligibility to the extracorporeal treatment, both for the treatment of severe cases of ARDS and for refractory shock, could lead to a greater number of patients treated and therefore saved.

However we cannot forget the  serious economic crisis that part of Europe is suffering, and the remarkable cut of the financial resources that seriously limits the possibility to carry out programs of widespread awareness campaign. Despite these hard limitations, other initiatives continue. A web-based interface for information ([www.ecmonet.org](www.ecmonet.org)) is continuously updated. A 24/24 hours and 7/7 days telephone Help-line ( 800 - 82 12 29 ) is always active in Italy for any kind of information and assistance. In engaging ourselves to keep alive the interest of the scientific community and looking forward to a "consensus conference" that will establish guidelines, we propose, as follows, the criteria of inclusion to the extracorporeal therapy.

**Pathological Processes Suitable for *venous-venous (V-V) ECMO***

Severe pneumoniaARDSAcute lung (graft) failure following transplantPulmonary contusionOthers:- Alveolar proteinosis- Smoke inhalation - Status asthmaticus- Airway obstruction- Aspiration syndromes

**Respiratory Indications to V-V ECMO**(after considering recruitment maneuvers, conventional or HFO protective lung ventilation, prone positioning, diuresis or renal replacement therapy for correction of volume overload, optimization of perfusion including restoration of oncotic pressure, intravascular volume, and inotropes). *Identify acute reversible pulmonary injury and select patients early in the course.*

Murray score \>3PaO2/FIO2 \<100 (mm Hg) despite high PEEP (10 -20 cmH2O) on FiO2 \>80%Others:- Intrapulmonary right-to-left shunt (Qs/QT) \>30%- Total thoracopulmonary compliance (CTstat) \<30 ml/cmH2O- Severe hypercapnia with PaCO2 \>80 on FiO2 \>90% or pH \<7.20- Maximal medical therapy \>48 h

**Contraindication to V-V ECMO**

**Absolute**

Irreversible cardiac or pulmonary diseaseMetastatic malignancySignificant brain injuryCurrent intracranial hemorrhageMajor pharmacologic immunosuppression (absolute neutrophil count \<400 )

**Relative**

Age \>65-70 years, considering increasing risk with increasing ageMechanical ventilation at high settings (FiO2 \>90%, Plateau Pressure \>30) \>7-10 daysMultitrauma with high risk of bleeding

**Pathological Processes Suitable for *venous-arterial (V-A) ECMO***

Cardiogenic shock: Acute Myocardial Infarction and complications (including: wall rupture, papillary muscle rupture, refractory ventricular tachycardia or fibrillation) refractory to conventional therapy including intraaortic balloon pumpPost cardiac surgery: unable to wean safely from cardiopulmonary bypass using conventional supportsDrug overdose with severe cardiac depressionMyocarditisEarly graft failure: post heart/heart-lung transplantOthers:- Pulmonary embolism- Cardiac or major vessel trauma- Massive hemoptysis/pulmonary hemorrhage- Pulmonary trauma- Acute anaphylaxis- Peri-partum cardiomyopathy- Sepsis with severe cardiac depression- Bridge to transplant

**Cardiac Indications to V-A ECMO**(shock persist despite volume administration, maximal inotropic and vasoconstrictors support, mechanical ventilation and intra-aortic balloon counterpulsation - if appropriate -)

Cardiac index \<2 L/min/m^2^Lactate level \>50 mg/dl or 5 mmol/L or Central Venous Oxygen Saturation - ScVO2 \<65% with maximum medical managementOthers:- Systolic blood pressure less than 90 mmHg- Low cardiac output

**Contraindication to V-A ECMO**

**Absolute**

Unrecoverable heart and not a candidate for transplant or Ventricular Assist Device (VAD)Age \>75 yearsChronic organ dysfunction (Emphysema, cirrhosis, renal failure)Prolonged Cardiopulmonary Resuscitation without adequate tissue perfusionAortic dissectionSevere aortic valve regurgitationCurrent intracranial hemorrhage

**Extracorporeal Cardiac Life Support (ECLS) - Extracorporeal Cardiopulmonary Resuscitation (ECPR)**

**Indications to V-A ECMO** include persistent cardiopulmonary arrest despite traditional resuscitative efforts.

**ECLS-ECPR Contraindications to V-A ECMO**

Initial rhythm asystoleAge \>80 yearsChest compressions not initiated within 10 min of arrest (either bystanders or emergency medical team)Cardiopulmonary Resuscitation \>60 min before implanting ECMOPre-existing severe neurological disease (including traumatic brain injury, stroke, or severe dementia)Current intracranial hemorrhageMalignancy in the terminal stageCardiac arrest of traumatic origin with uncontrolled bleedingIrreversible organ failure leading to cardiac arrest when no physiological benefit could be expected despite maximal therapy
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